Targeting Cardiomyocyte Ca2 Homeostasis in Heart Failure

By  

Current Pharmaceutical Design, Vol. 21, Iss. 4, 2015-02 ,pp. : 431-448

Bentham Science Publishers

Access to resources Recommend Favorite

Ca2+-Handling Proteins and Heart Failure: Novel Molecular Targets?

By  

Current Medicinal Chemistry, Vol. 10, Iss. 11, 2003-06 ,pp. : 967-981

Bentham Science Publishers

Access to resources Recommend Favorite

Angiotensin‐converting enzyme 2–Angiotensin 1‐7/1‐9 system: novel promising targets for heart failure treatment

By  

Fundamental & Clinical Pharmacology, Vol. 32, Iss. 1, 2018-02 ,pp. : 14-25

John Wiley & Sons Inc

Access to resources Recommend Favorite

Triple Threat: The Na+/Ca2+ Exchanger in the Pathophysiology of Cardiac Arrhythmia, Ischemia and Heart Failure

By  

Current Drug Targets, Vol. 12, Iss. 5, 2011-05 ,pp. : 737-747

Bentham Science Publishers

Access to resources Recommend Favorite

Chromogranins and Inositol 1,4,5-Trisphosphate-Dependent Ca2+-Signaling in Cardiomyopathy and Heart Failure

By  

Current Medicinal Chemistry, Vol. 19, Iss. 24, 2012-01 ,pp. : 4068-4073

Bentham Science Publishers

Access to resources Recommend Favorite